Senhwa completes IPO

Cancer company Senhwa Biosciences Inc. (TPEx:6492) raised NT$1.4 billion ($45.4 million) through the sale of 8.5 million shares at NT$162 in an IPO underwritten by SinoPac Securities. The company beg...